Deutsch English Français

Contact

EP3362047

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP3362047

EP3362047 - LOW DOSE ORAL DIPYRIDAMOLE COMPOSITIONS AND USES THEREOF [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 10.09.2021 Database last updated on 17.09.2024
Former	Examination is in progress Status updated on 30.10.2020
Former	Request for examination was made Status updated on 20.07.2018
Former	The international publication has been made Status updated on 21.04.2017
Most recent event Tooltip	10.09.2021	Application deemed to be withdrawn	published on 13.10.2021 [2021/41]
Applicant(s)	For all designated states Drug Rediscovery Group Ltd Pekeris 4 7670204 Rehovot / IL
	[2019/49]
Former [2018/34]	For all designated states Rogosnitzky, Moshe Yitzchak 37 9083800 Kiryat Yearmin / IL
Inventor(s)	01 / ROGOSNITZKY Moshe Yitzchak 37 Kiryat Yearim 9083800 / IL
	[2019/49]
Former [2018/34]	01 / see applicant ...
Representative(s)	Herrmann, Johanna Industrial Property Services GmbH Rosenweg 14 4303 Kaiseraugst / CH
	[2018/34]
Application number, filing date	16855041.6	14.10.2016
	[2018/34]
	WO2016IB56151
Priority number, date	US201562241771P	15.10.2015 Original published format: US 201562241771 P
	US201662325516P	21.04.2016 Original published format: US 201662325516 P
	[2018/34]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2017064652
	Date:	20.04.2017
	Language:	EN
	[2017/16]
	Type:	A2 Application without search report
	No.:	EP3362047
	Date:	22.08.2018
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 20.04.2017 takes the place of the publication of the European patent application.
	[2018/34]
Search report(s)	International search report - published on:	US	29.06.2017
	(Supplementary) European search report - dispatched on:	EP	24.05.2019
Classification	IPC:	A61K9/08, A61K9/20, A61K9/48, A61K31/505, A61K31/519, A61K47/10, A61P27/04, A61P29/02, A61P25/20, A61P15/10, A61P31/12, A61K9/00, A61K31/4045	[2019/25]
	CPC:	A61K31/519 (EP,KR,US); A61K31/4045 (EP,KR,US); A61K47/10 (EP,KR,US); A61K9/0053 (US); A61K9/08 (EP,KR,US); A61K9/4866 (EP,KR,US); (+) A61P15/10 (EP,KR,US); A61P25/20 (EP,KR,US); A61P27/04 (EP,US); A61P29/02 (EP,US); A61P31/12 (EP,KR,US); A61K2300/00 (KR,US) (-)
	C-Set:	A61K31/4045, A61K2300/00 (US,EP); A61K31/519, A61K2300/00 (EP,US)
	Former IPC [2018/34]	A61K9/08, A61K9/20, A61K9/48, A61K31/505, A61K31/519, A61K47/10
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/34]
Title	German:	NIEDRIGDOSIERTE ORALE DIPYRIDAMOLZUSAMMENSETZUNGEN UND VERWENDUNGEN DAVON	[2018/34]
	English:	LOW DOSE ORAL DIPYRIDAMOLE COMPOSITIONS AND USES THEREOF	[2018/34]
	French:	COMPOSITIONS DE DIPYRIDAMOLE FAIBLEMENT DOSÉES À ADMINISTRATION ORALE ET UTILISATIONS ASSOCIÉES	[2018/34]
Entry into regional phase	11.05.2018	National basic fee paid
	11.05.2018	Search fee paid
	11.05.2018	Designation fee(s) paid
	11.05.2018	Examination fee paid
Examination procedure	11.05.2018	Examination requested [2018/34]
	11.05.2018	Date on which the examining division has become responsible
	06.10.2019	Amendment by applicant (claims and/or description)
	29.10.2020	Despatch of a communication from the examining division (Time limit: M06)
	11.05.2021	Application deemed to be withdrawn, date of legal effect [2021/41]
	08.06.2021	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2021/41]
Fees paid	Renewal fee
	11.05.2018	Renewal fee patent year 03
	25.09.2019	Renewal fee patent year 04
	14.09.2020	Renewal fee patent year 05
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[I]CN1279066 (YANAN HOSPITAL KUNMING CITY [CN]) [I] 1-5,12 * example 2 *;
		[A] - BALAKUMAR PITCHAI ET AL, "Classical and pleiotropic actions of dipyridamole: Not enough light to illuminate the dark tunnel?", PHARMACOLOGICAL RESEARCH, (201409), vol. 87, ISSN 1043-6618, pages 144 - 150, XP055588614 [A] 1-15 * the whole document * DOI: http://dx.doi.org/10.1016/j.phrs.2014.05.008
	International search	[Y]US6586478 (ACKMAN C BRUCE [CA], et al) [Y] 6, 16, 29-30 * ; column 3, lines 9-35; column 8, lines 57-61; column 10, lines 46-50 *;
		[XY]CN1586484 (RUIYIREN SCIENCE AND TECHNOLOG [CN]) [X] 1, 3, 5, 28, 33, 36, 42 * (English translation); claims 1 and 7, page 2, second column, twelfth-thirteenth paragraphs; page 3, second column, fourth-fifth, seventh, and thirteenth paragraphs; page 4, third paragraph and embodiment 1 * [Y] 2, 19, 22, 29-32, 34-35, 37-41;
		[Y]US2006211664 (DUDLEY ROBERT E [US]) [Y] 20, 34 * ; claim 9, paragraphs [0023], [0035], [0093] *;
		[XY]US2006234991 (KEITH CURTIS [US], et al) [X] 1, 4, 14, 24 * ; paragraph [0004], [0007]-[0008],[0013]-[0019], [0030], [0034]-[0035], [0038]-[0039], [0043] * [Y] 6, 15-23, 25-27, 29;
		[Y]US2007021391 (DOI TAKAYUKI [JP], et al) [Y] 25, 39 * : paragraphs [0622], [0641] *;
		[Y]CN1969947 (BEIJING QI YUAN YI PHARM RES [CN]) [Y] 18, 32 * (English translation); claim 1; page 3, second-third paragraphs *;
		[X]US2007213308 (LESSEM JAN N [US], et al) [X] 7-14, 24 26, 38, 40 * ; paragraphs [0003], [0010], [0012], [0014], [0019], [0038], [0126], [0130]-[0133],[0136], [0211] *;
		[Y]US2014107130 (TAMBI BRIAN [US], et al) [Y] 2 * ; paragraphs [0004], [0007], [0014] *;
		[Y]US2015031712 (ROGOSNITZKY MOSHE [IL]) [Y] 17, 31 * ; paragraphs [0049], [0076], [0097] *;
		[Y]WO2015110923 (ACERTA PHARMA BV [NL]) [Y] 21, 35 * ; paragraphs [0013], [00262] *;
		[Y] - COSTELLO RB et al., "The Effectiveness of Melatonin for Promoting Healthy Sleep: a Rapid Evidence Assessment of the Literature", Nutrition Journal, (20140000), vol. 13, no. 106, pages 1 - 17, XP 021203420 [Y] 6, 15, 29 * ; page 12, second column, last paragraph; page 13, second column, second paragraph; page 17, first column, second paragraph *
		[Y] - CHEN L et al., "Antinociceptive Effect of Prostatic Acid Phosphatase in a Rat Model of Cancer-Induced Bone Pain", Pain Physician, (20130000), vol. 16, pages 533 - 546, XP 055395863 [Y] 23, 37 * ; page 541, second column, last paragraph; page 542, first column, last paragraph; page 534, first column, third paragraph; page 546, first column, last paragraph, second column, first paragraph *
		[Y] - SINGH D et al., "Phase II Trial of 5-Fluorouracil, High-Dose Leucovorin Calcium, and Dipyridamole in Advanced Prostate Cancer", Journal of Cancer Research and Clinical Oncology, (19920000), vol. 119, no. 2, pages 117 - 120, XP009509360 [Y] 27, 41 * (abstract); abstract * DOI: http://dx.doi.org/10.1007/BF01209667
		[Y] - FAGHIHI G et al., "Comparison of the Efficacy of Topical Minoxidil 5% and Adenosine 0.75% Solutions on Male Androgenetic Alopecia and Measuring Patient Satisfaction Rate", Acta Dermatovenerol Croat, (20130000), vol. 21, no. 3, pages 155 - 159, XP 055523132 [Y] 26, 40 * ; page 156, first column, first paragraph; page 158, second column, first paragraph *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p